[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030. Including: By Type Of Pharmaceutical: Veterinary Parasiticides; Veterinary Vaccines; Others - Veterinary Pharmaceuticals; Veterinary Antibiotics. By Animal Type: Livestock; Companion Animal. By Route of Administration: Oral; Others. By End-Use: Veterinary Hospitals; Pharmacies And Drug Stores; Veterinary Clinics. Covering: Zoetis Inc.; Boehringer Ingelheim International GmbH; Merck & Co., Inc.; Elanco Animal Health Inc.; Bayer AG

January 2020 | 486 pages | ID: VE4909C9A9D5EN
The Business Research Company

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
If ordered it will be delivered within 3-5 business days.

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market.

Reasons to Purchase
  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
Description:

Where is the largest and fastest growing market for the veterinary pharmaceuticals market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global veterinary pharmaceutical market report to 2030 from the Business Research Company answers all these questions and many more.

The report covers the following chapters
  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by type.
  • Market Characteristics – The market characteristics section of the report defines and explains the veterinary pharmaceuticals market. This chapter includes different goods covered in the report and basic definitions.
  • Supply Chain – The supply chain section of the report defines and explains the key players in the veterinary pharmaceuticals industry supply chain.
  • Product Analysis – The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
  • Customer Information – This chapters covers recent customers’ trends/preferences in the global veterinary pharmaceuticals market.
  • Trends And Strategies – This chapter describes the major trends shaping the global veterinary pharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Regulatory Landscape – This section describes the current regulatory scenario, the regional disparities in regulations, global regulation harmonization initiatives, and recent updates on veterinary pharmaceutical regulations.
  • Impact Of Veterinary Services On The Veterinary Pharmaceuticals Market – This chapter describes the impact of veterinary services on the veterinary pharmaceuticals market, and comparison between the veterinary services, veterinary medical equipment and veterinary pharmaceuticals markets across major countries.
  • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2023, 2025 and 2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Market Segmentation – This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments and sub-segments in the market.
  • Regional And Country Analysis – This section contains the historic (2015-2019), forecast (2023, 2025 and 2030) market value and growth and market share comparison by region and countries.
  • Regional Market Size And Growth – This section contains the region’s market size (2019), historic and forecast (2015-2019, 2023, 2025 and 2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape – This section covers details on the competitive landscape of the global veterinary pharmaceuticals market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background – This section describes the animal medicine market of which the veterinary pharmaceuticals market is a segment. This chapter includes the animal medicine market 2015-23 values, and regional analyses for the animal medicine market.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report
Markets Covered:

By Type Of Pharmaceutical: Veterinary Parasiticides; Veterinary Vaccines; Others - Veterinary Pharmaceuticals; Veterinary Antibiotics

By Animal Type: Livestock; Companion Animal

By Route of Administration: Oral; Others

By End-Use: Veterinary Hospitals; Pharmacies And Drug Stores; Veterinary Clinics

Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim International GmbH; Merck & Co., Inc.; Elanco Animal Health Inc.; Bayer AG

Countries: China, India, Japan, Australia, South Korea, Indonesia, USA, Brazil, UK, Germany, France, Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. VETERINARY PHARMACEUTICALS MARKET EXECUTIVE SUMMARY

2. TABLE OF CONTENTS

3. LIST OF FIGURES

4. LIST OF TABLES

5. REPORT STRUCTURE

6. INTRODUCTION

  6.1.1. Segmentation By Geography
  6.1.2. By Type Of Pharmaceutical
  6.1.3. Segmentation By Animal Type
  6.1.4. Segmentation By Route of Administration
  6.1.5. Segmentation By End Use Channel

7. VETERINARY PHARMACEUTICALS MARKET CHARACTERISTICS

7.1. Market Definition
7.2. Market Segmentation By Type Of Product
  7.2.1. Veterinary Vaccines
  7.2.2. Veterinary Antibiotics
  7.2.3. Veterinary Parasiticides
  7.2.4. Others - Veterinary Pharmaceuticals
7.3. Market Segmentation By End User
  7.3.1. Veterinary Hospitals
  7.3.2. Veterinary Clinics
  7.3.3. Pharmacies And Drug Stores
7.4. Market Segmentation By Route Of Administration
  7.4.1. Oral
  7.4.2. Others
7.5. Market Segmentation By Type Of Animal
  7.5.1. Livestock
  7.5.2. Companion Animals
7.6. Market Segmentation By Vaccines
  7.6.1. Inactivated Vaccines
  7.6.2. Attenuated Vaccines
  7.6.3. Recombinant Vaccines
  7.6.4. Others
7.7. Market Segmentation By Antibiotics
  7.7.1. Tetracyclines
  7.7.2. Penicillins
  7.7.3. Sulphonamides
  7.7.4. Macrolides
  7.7.5. Aminoglycosides
  7.7.6. Others

8. VETERINARY PHARMACEUTICALS MARKET, SUPPLY CHAIN ANALYSIS

  8.1.1. Raw Material Suppliers
  8.1.2. Contract Research Organization (CRO)
  8.1.3. Veterinary Pharmaceutical Manufacturer
  8.1.4. Contract Manufacturing Organization (CMO)
  8.1.5. Wholesalers/Distributors
  8.1.6. Retailers (Pharmacies And Veterinary Shops) And Veterinary Clinics
  8.1.7. End-Users

9. VETERINARY PHARMACEUTICALS MARKET, PRODUCT ANALYSIS –PRODUCT EXAMPLES

10. VETERINARY PHARMACEUTICALS MARKET CUSTOMER INFORMATION

  10.1.1. Opioids Shortages Compel Veterinarians To Use Less Effective Drugs As Therapeutic Choices
  10.1.2. U.S. Veterinarians Are Reluctant To Discuss The Therapeutic Use Of Marijuana In Dogs
  10.1.3. Pet Ownership In The USA Has Tripled Over The Past Few Years
  10.1.4. Cat And Dog Medications Are Still Sold Mainly In Veterinary Clinics
  10.1.5. Pet Insurance Penetration In The USA Is Very Low
  10.1.6. Pet Obesity Remains A Big Issue
  10.1.7. The More Pet Owners Learn About Scientific Research On The Benefits Of The Human-Animal Bond, The More Likely They Are To Take Actions To Improve Pet Health.
  10.1.8. Dog And Cat Owners Alike Are Concerned About The Cost Of Medical Treatments For Their Pets

11. VETERINARY PHARMACEUTICALS MARKET TRENDS AND STRATEGIES

11.1. Strategic Collaborations And Partnerships To Drive Innovations
11.2. Development Of Chewable Tablets
11.3. Production Of Generic Drugs For Animal Care
11.4. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
11.5. Oral Drug Solutions For The Treatment Of Feline Hypertension
11.6. Use of Subunit And Virus-Like Particle (VLP)-Based Vaccines
11.7. Use Of Immunotherapy

12. GLOBAL VETERINARY PHARMACEUTICALS MARKET REGULATORY LANDSCAPE

12.1. Need For Separate Regulation For The Veterinary Pharmaceuticals Industry
12.2. Current Regulatory Scenario
  12.2.1. USA
  12.2.2. Europe
  12.2.3. India
  12.2.4. Brazil
  12.2.5. Australia and New Zealand
  12.2.6. Africa
12.3. Regional Disparities In Regulations
  12.3.1. Lack Of Regulatory Guidance
  12.3.2. Variations In Veterinary Pharmaceuticals Development Processes
  12.3.3. Variations In Safety Considerations For Veterinary Pharmaceuticals
  12.3.4. Differences In Registration Procedures
12.4. Global Regulation Harmonization Initiatives
12.5. Recent Updates On Veterinary Pharmaceutical Regulations

13. IMPACT OF VETERINARY SERVICES ON THE VETERINARY PHARMACEUTICALS MARKET

  13.1.1. USA
  13.1.2. Japan
  13.1.3. China
  13.1.4. UK
  13.1.5. Germany

14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE AND GROWTH

14.1. Historic And Forecast Market Growth, Value ($ Million)
  14.1.1. Drivers Of The Market 2015-2019
  14.1.2. Emerging Markets Growth
  14.1.3. Increased Pet Spending
  14.1.4. Increased Disease Prevalence
  14.1.5. Restraints On The Market 2015-2019
  14.1.6. Shortages Of Veterinarians
  14.1.7. Drivers Of The Market 2019-2023
  14.1.8. Economic Growth
  14.1.9. Increasing Penetration Of Pet Insurance
  14.1.10. Restraints On The Market 2019-2023

15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SEGMENTATION

15.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.4. Global Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SUB-SEGMENTATION

16.1. Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.2. Global Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

17. VETERINARY PHARMACEUTICALS MARKET, REGIONAL AND COUNTRY ANALYSIS

17.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

18. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET

18.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
  18.1.1. Region Information
  18.1.2. Market Information
  18.1.3. Background Information
  18.1.4. Government Initiatives
  18.1.5. Regulatory Bodies
  18.1.6. Regulations
  18.1.7. Corporate Tax Structure
  18.1.8. Associations
  18.1.9. Tax Levied
  18.1.10. Investments
  18.1.11. Major Companies
18.2. Asia-Pacific Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.3. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.6. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.7. Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
18.8. China Veterinary Pharmaceuticals Market
18.9. China Veterinary Pharmaceuticals Market Overview
  18.9.1. Country Information
  18.9.2. Market Information
  18.9.3. Background Information
  18.9.4. Regulatory Bodies
  18.9.5. Regulations
  18.9.6. Corporate Tax Structure
  18.9.7. Associations
  18.9.8. Tax Levied
  18.9.9. Investments
  18.9.10. Major Companies
18.10. China Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.11. China Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.12. China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.13. China Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.14. China Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.15. India Veterinary Pharmaceuticals Market
18.16. India Veterinary Pharmaceuticals Market Overview
  18.16.1. Country Information
  18.16.2. Market Information
  18.16.3. Background Information
  18.16.4. Government Initiatives
  18.16.5. Regulatory Bodies
  18.16.6. Regulations
  18.16.7. Corporate Tax Structure
  18.16.8. Associations
  18.16.9. Tax Levied
  18.16.10. Investments
  18.16.11. Major Companies
18.17. India Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.18. India Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.19. India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.20. India Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.21. India Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.22. Japan Veterinary Pharmaceuticals Market
18.23. Japan Veterinary Pharmaceuticals Market Overview
  18.23.1. Country Information
  18.23.2. Market Information
  18.23.3. Background Information
  18.23.4. Government Initiatives
  18.23.5. Regulatory Bodies
  18.23.6. Regulations
  18.23.7. Corporate Tax Structure
  18.23.8. Associations
  18.23.9. Tax Levied
  18.23.10. Investments
  18.23.11. Major Companies
18.24. Japan Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.25. Japan Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.26. Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.27. Japan Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.28. Japan Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.29. Australia Veterinary Pharmaceuticals Market
18.30. Australia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.31. Australia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.32. Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.33. Australia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.34. Australia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.35. Indonesia Veterinary Pharmaceuticals Market
18.36. Indonesia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.37. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.38. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.39. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.40. Indonesia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.41. South Korea Veterinary Pharmaceuticals Market
18.42. South Korea Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
18.43. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.44. South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.45. South Korea Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.46. South Korea Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

19. WESTERN EUROPE VETERINARY PHARMACEUTICALS MARKET

19.1. Western Europe Veterinary Pharmaceuticals Market Overview
  19.1.1. Region Information
  19.1.2. Market Information
  19.1.3. Background Information
  19.1.4. Government Initiatives
  19.1.5. Regulatory Bodies
  19.1.6. Regulations
  19.1.7. Corporate Tax Structure
  19.1.8. Associations
  19.1.9. Investments
  19.1.10. Major Companies
19.2. Western Europe Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
19.3. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.6. Western Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.7. Western Europe Veterinary Pharmaceuticals Market: Country Analysis
19.8. UK Veterinary Pharmaceuticals Market
19.9. UK Veterinary Pharmaceuticals Market Overview
  19.9.1. Country Information
  19.9.2. Market Information
  19.9.3. Background Information
  19.9.4. Government Initiatives
  19.9.5. Regulatory Bodies
  19.9.6. Regulations
  19.9.7. Corporate Tax Structure
  19.9.8. Associations
  19.9.9. Investments
  19.9.10. Major Companies
19.10. UK Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
19.11. UK Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.12. UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.13. UK Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.14. UK Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.15. Germany Veterinary Pharmaceuticals Market
19.16. Germany Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
19.17. Germany Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.18. Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.19. Germany Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.20. Germany Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.21. France Veterinary Pharmaceuticals Market
19.22. France Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
19.23. France Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.24. France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.25. France Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.26. France Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

20. EASTERN EUROPE VETERINARY PHARMACEUTICALS MARKET

20.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
  20.1.1. Region Information
  20.1.2. Market Information
  20.1.3. Background Information
  20.1.4. Regulatory Bodies
  20.1.5. Regulations
  20.1.6. Corporate Tax Structure
  20.1.7. Associations
  20.1.8. Tax Levied
  20.1.9. Investment
  20.1.10. Major Companies
20.2. Eastern Europe Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
20.3. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.6. Eastern Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.7. Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis
20.8. Russia Veterinary Pharmaceuticals Market
20.9. Russia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
20.10. Russia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.11. Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.12. Russia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.13. Russia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

21. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET

21.1. North America Veterinary Pharmaceuticals Market Overview
  21.1.1. Region Information
  21.1.2. Market Information
  21.1.3. Background Information
  21.1.4. Government Initiatives
  21.1.5. Regulatory Bodies
  21.1.6. Regulations
  21.1.7. Corporate Tax Structure
  21.1.8. Associations
  21.1.9. Tax Levied
  21.1.10. Investments
  21.1.11. Major Companies
21.2. North America Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
21.3. North America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.4. North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.5. North America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.6. North America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.7. North America Veterinary Pharmaceuticals Market: Country Analysis
21.8. USA Veterinary Pharmaceuticals Market
21.9. USA Veterinary Pharmaceuticals Market Overview
  21.9.1. Region Information
  21.9.2. Market Information
  21.9.3. Background Information
  21.9.4. Government Initiatives
  21.9.5. Regulatory Bodies
  21.9.6. Regulations
  21.9.7. Corporate Tax Structure
  21.9.8. Associations
  21.9.9. Tax Levied
  21.9.10. Investments
  21.9.11. Major Companies
21.10. USA Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
21.11. USA Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.12. USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.13. USA Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.14. USA Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

22. SOUTH AMERICA VETERINARY PHARMACEUTICALS MARKET

22.1. South America Veterinary Pharmaceuticals Market Overview
  22.1.1. Region Information
  22.1.2. Market Information
  22.1.3. Background Information
  22.1.4. Regulatory Bodies
  22.1.5. Regulations
  22.1.6. Corporate Tax Structure
  22.1.7. Associations
  22.1.8. Tax Levied
  22.1.9. Investments
  22.1.10. Major Companies
22.2. South America Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
22.3. South America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.4. South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.5. South America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.6. South America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.7. South America Veterinary Pharmaceuticals Market: Country Analysis
22.8. Brazil Veterinary Pharmaceuticals Market
22.9. Brazil Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
22.10. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.11. Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.13. Brazil Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

23. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET

23.1. Middle East Veterinary Pharmaceuticals Market Overview
  23.1.1. Region Overview
  23.1.2. Market Information
  23.1.3. Background Information
  23.1.4. Regulatory Bodies
  23.1.5. Regulations
  23.1.6. Corporate Tax Structure
  23.1.7. Associations
  23.1.8. Major Companies
23.2. Middle East Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
23.3. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
23.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
23.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
23.6. Middle East Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

24. AFRICA VETERINARY PHARMACEUTICALS MARKET

24.1. Africa Veterinary Pharmaceuticals Market Overview
  24.1.1. Region Information
  24.1.2. Market Information
  24.1.3. Background Information
  24.1.4. Regulatory Bodies
  24.1.5. Regulations
  24.1.6. Corporate Tax Structure
  24.1.7. Associations
  24.1.8. Investments
  24.1.9. Major Companies
24.2. Africa Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
24.3. Africa Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
24.4. Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
24.5. Africa Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
24.6. Africa Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

25. GLOBAL VETERINARY PHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE

25.1. Company Profiles
25.2. Zoetis Inc.
  25.2.1. Company Overview
  25.2.2. Products And Services
  25.2.3. Business Strategy
  25.2.4. Financial Overview
25.3. Boehringer Ingelheim International GmbH
  25.3.1. Company Overview
  25.3.2. Products And Services
  25.3.3. Business Strategy
  25.3.4. Financial Overview
25.4. Merck & Co., Inc.
  25.4.1. Company Overview
  25.4.2. Products And Services
  25.4.3. Business Strategy
  25.4.4. Financial Overview
25.5. Elanco Animal Health Inc.
  25.5.1. Company Overview
  25.5.2. Products And Services
  25.5.3. Business Strategy
  25.5.4. Financial Overview
25.6. Bayer AG
  25.6.1. Company Overview
  25.6.2. Products And Services
  25.6.3. Business Strategy
  25.6.4. Financial overview

26. KEY MERGERS AND ACQUISITIONS IN THE VETERINARY PHARMACEUTICALS MARKET

26.1. Elanco Animal Health Acquired Bayer’s AG
26.2. Merck Animal Health Acquired Antelliq Corporation
26.3. Henry Schein Animal Health Merges With Vets First Choice
26.4. Mars Petcare Acquired AniCura
26.5. PHARMAQ Collaborated With Vinh Hoan
26.6. Animal Health Division Of Merck & Co. Collaborated With Vinovo
26.7. Wageningen Bioveterinary Research Collaborated With Ceva
26.8. Animalcare Group Acquired Ecuphar
26.9. Merck Animal Health Acquired Vallee S.A.
26.10. Elanco Animal Health Acquired Boehringer Ingelheim Vetmedica’s Vaccine Portfolio
26.11. Ceva Acquired Portfolio Of Merial Swine And Cattle Vaccines
26.12. Dechra Holdings US (A U.S Subsidiary of Dechra Pharmaceuticals PLC Acquired Putney Inc.
26.13. Zydus Cadila Acquired Zoetis
26.14. Eli Lilly And Company Acquired Novartis Animal Health

27. MARKET BACKGROUND: ANIMAL MEDICINE

27.1. Animal Medicine Market Characteristics
  27.1.1. Market Definition
  27.1.2. Segmentation Type Of Medicine
27.2. Global Animal Medicine Market, Segmentation By Industry, 2015 - 2023, Value ($ Million)
27.3. Global Animal Medicine Market, 2019, By Region, Value ($ Million)
27.4. Global Animal Medicine Market, 2015 - 2023, Historic And Forecast, By Region

28. GLOBAL VETERINARY PHARMACEUTICALS MARKET OPPORTUNITIES AND STRATEGIES

28.1. Global Veterinary Pharmaceuticals Market In 2023 – Countries Offering Most New Opportunities
28.2. Global Veterinary Pharmaceuticals Market In 2023 – Segments Offering Most New Opportunities
28.3. Global Veterinary Pharmaceuticals Market In 2023 – Growth Strategies
  28.3.1. Market Trend Based Strategies
  28.3.2. Competitor Strategies

29. VETERINARY PHARMACEUTICALS MARKET, CONCLUSIONS AND RECOMMENDATIONS

29.1. Conclusions
29.2. Recommendations
  29.2.1. Product
  29.2.2. Place
  29.2.3. Price
  29.2.4. Promotion
  29.2.5. People

30. APPENDIX

30.1. Market Data Sources
30.2. Research Methodology
30.3. Currencies
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright and Disclaimer


More Publications